Li S - Search Results

1

Novel selective cannabinoid CB(1) receptor antagonist MJ08 with potent in vivo bioactivity and inverse agonistic effects.

Chen W, Xu C, Liu HY, Long L, Zhang W, Zheng ZB, Xie YD, Wang LL, Li S. Chen W, et al. Among authors: li s. Acta Pharmacol Sin. 2011 Sep;32(9):1148-58. doi: 10.1038/aps.2011.80. Epub 2011 Aug 15. Acta Pharmacol Sin. 2011. PMID: 21841814 Free PMC article.

2

Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.

Chen W, Tang H, Liu H, Long L, Gong Z, Zheng J, Chi M, Xie Y, Zheng Z, Li S, Wang L. Chen W, et al. Among authors: li s. Eur J Pharmacol. 2010 Jul 10;637(1-3):178-85. doi: 10.1016/j.ejphar.2010.03.040. Epub 2010 Apr 7. Eur J Pharmacol. 2010. PMID: 20380831

3

Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats.

Chen W, Chen Z, Xue N, Zheng Z, Li S, Wang L. Chen W, et al. Among authors: li s. Naunyn Schmiedebergs Arch Pharmacol. 2013 Aug;386(8):721-32. doi: 10.1007/s00210-013-0875-y. Epub 2013 Apr 26. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23620336

4

C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats.

Cheng G, Wang LL, Qu WS, Long L, Cui H, Liu HY, Cao YL, Li S. Cheng G, et al. Among authors: li s. Acta Pharmacol Sin. 2005 Dec;26(12):1460-6. doi: 10.1111/j.1745-7254.2005.00240.x. Acta Pharmacol Sin. 2005. PMID: 16297344

5

C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.

Xu C, Wang LL, Liu HY, Zhou XB, Cao YL, Li S. Xu C, et al. Among authors: li s. Acta Pharmacol Sin. 2006 Feb;27(2):223-8. doi: 10.1111/j.1745-7254.2006.00263.x. Acta Pharmacol Sin. 2006. PMID: 16412273

6

Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.

Chen W, Wang LL, Liu HY, Long L, Li S. Chen W, et al. Among authors: li s. Basic Clin Pharmacol Toxicol. 2008 Sep;103(3):240-6. doi: 10.1111/j.1742-7843.2008.00268.x. Epub 2008 Jul 18. Basic Clin Pharmacol Toxicol. 2008. PMID: 18684227 Free article.

7

P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.

Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S. Chen W, et al. Among authors: li s. Br J Pharmacol. 2009 Jul;157(5):724-35. doi: 10.1111/j.1476-5381.2009.00231.x. Epub 2009 May 5. Br J Pharmacol. 2009. PMID: 19422369 Free PMC article.

8

Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).

Li X, Wang L, Long L, Xiao J, Hu Y, Li S. Li X, et al. Among authors: li s. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4868-72. doi: 10.1016/j.bmcl.2009.04.066. Epub 2009 Apr 20. Bioorg Med Chem Lett. 2009. PMID: 19616940

9

[Establishment of a diabetic-hypertensive rat model].

Zhang B, Cheng G, Liu HY, Wang LL, Li S. Zhang B, et al. Among authors: li s. Yao Xue Xue Bao. 2009 Jun;44(6):575-80. Yao Xue Xue Bao. 2009. PMID: 19806885 Chinese.

10

(S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl) propanoic acid compounds: synthesis and biological evaluation of dual PPARalpha/gamma agonists.

Zhou X, Chen W, Xu C, Fan S, Xie Y, Zhong W, Wang L, Li S. Zhou X, et al. Among authors: li s. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2605-8. doi: 10.1016/j.bmcl.2010.02.071. Epub 2010 Mar 1. Bioorg Med Chem Lett. 2010. PMID: 20299214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100,513 results

Search Page

Filters